ADX-71149
Tier C — Watch / tradeADX-71149
Targets：GRM2
Indications (approved)：Seizure, Major depressive disorder, Schizophrenia, 意识错乱, 知觉障碍
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| ADX-71149 | 1127498-03-6 | 1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2(1H)-one |
| ADX-71149-001 | 53937-02-3 | 4-(benzyloxy)pyridin-2(1H)-one |
| ADX-71149-002 | 109-65-9 | 1-bromobutane |
| ADX-71149-003 | 1127499-16-4 | 4-(benzyloxy)-1-butylpyridin-2(1H)-one |
| ADX-71149-004 | 1127499-19-7 | 1-butyl-4-hydroxypyridin-2(1H)-one |
| ADX-71149-005 | 1127499-22-2 | 4-bromo-1-butylpyridin-2(1H)-one |
| ADX-71149-006 | 771-99-3 | 4-phenylpiperidine |
| ADX-71149-007 | 1127499-59-5 | 1-butyl-4-(4-phenylpiperidin-1-yl)pyridin-2(1H)-one |
Frequently asked questions
What are the approved indications of ADX-71149?
Approved indications include: Seizure, Major depressive disorder, Schizophrenia, 意识错乱, 知觉障碍.
When does the ADX-71149 patent expire?
No public expiry year is available for ADX-71149 yet; this page updates once verified.
How many synthesis routes are recorded for ADX-71149?
1 synthesis routes are recorded; the shortest is 5 steps with 0.39 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy ADX-71149 intermediates?
All intermediates in ADX-71149 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for ADX-71149 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-19